217 related articles for article (PubMed ID: 11831872)
1. Involvement of ADAM9 in multinucleated giant cell formation of blood monocytes.
Namba K; Nishio M; Mori K; Miyamoto N; Tsurudome M; Ito M; Kawano M; Uchida A; Ito Y
Cell Immunol; 2001 Nov; 213(2):104-13. PubMed ID: 11831872
[TBL] [Abstract][Full Text] [Related]
2. Cross-talk between RANKL and FRP-1/CD98 Systems: RANKL-mediated osteoclastogenesis is suppressed by an inhibitory anti-CD98 heavy chain mAb and CD98-mediated osteoclastogenesis is suppressed by osteoclastogenesis inhibitory factor.
Mori K; Miyamoto N; Higuchi Y; Nanba K; Ito M; Tsurudome M; Nishio M; Kawano M; Uchida A; Ito Y
Cell Immunol; 2001 Feb; 207(2):118-26. PubMed ID: 11243701
[TBL] [Abstract][Full Text] [Related]
3. Suppression of FRP-1/CD98-mediated multinucleated giant cell and osteoclast formation by an anti-FRP-1/CD98 mAb, HBJ 127, that inhibits c-src expression.
Tajima M; Higuchi S; Higuchi Y; Miyamoto N; Uchida A; Ito M; Nishio M; Komada H; Kawano M; Kusagawa S; Tsurudome M; Ito Y
Cell Immunol; 1999 May; 193(2):162-9. PubMed ID: 10222058
[TBL] [Abstract][Full Text] [Related]
4. Expression of ADAM9 (meltrin-gamma) around aseptically loosened total hip replacement implants.
Ma GF; Liljeström M; Ainola M; Chen T; Tiainen VM; Lappalainen R; Konttinen YT; Salo J
Rheumatology (Oxford); 2006 Jul; 45(7):808-14. PubMed ID: 16418197
[TBL] [Abstract][Full Text] [Related]
5. ADAM gene expression and regulation during human osteoclast formation.
Verrier S; Hogan A; McKie N; Horton M
Bone; 2004 Jul; 35(1):34-46. PubMed ID: 15207739
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of fusion regulatory protein-1 (FRP-1) that induces multinucleated giant cell formation of monocytes and HIV gp160-mediated cell fusion. FRP-1 and 4F2/CD98 are identical molecules.
Ohgimoto S; Tabata N; Suga S; Nishio M; Ohta H; Tsurudome M; Komada H; Kawano M; Watanabe N; Ito Y
J Immunol; 1995 Oct; 155(7):3585-92. PubMed ID: 7561057
[TBL] [Abstract][Full Text] [Related]
7. Characterization of two types of osteoclasts from human peripheral blood monocytes.
Yuasa K; Mori K; Ishikawa H; Sudo A; Uchida A; Ito Y
Biochem Biophys Res Commun; 2007 May; 356(2):354-60. PubMed ID: 17368425
[TBL] [Abstract][Full Text] [Related]
8. Cytological properties of stromal cells derived from giant cell tumor of bone (GCTSC) which can induce osteoclast formation of human blood monocytes without cell to cell contact.
Nishimura M; Yuasa K; Mori K; Miyamoto N; Ito M; Tsurudome M; Nishio M; Kawano M; Komada H; Uchida A; Ito Y
J Orthop Res; 2005 Sep; 23(5):979-87. PubMed ID: 16024207
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of formation of multinucleated giant cells from concanavalin A-stimulated human blood monocytes by IFN-gamma and IL-4.
Takashima T; Ohnishi K; Tsuyuguchi I; Kishimoto S
J Immunol; 1993 Apr; 150(7):3002-10. PubMed ID: 8454870
[TBL] [Abstract][Full Text] [Related]
10. Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts.
Kindle L; Rothe L; Kriss M; Osdoby P; Collin-Osdoby P
J Bone Miner Res; 2006 Feb; 21(2):193-206. PubMed ID: 16418775
[TBL] [Abstract][Full Text] [Related]
11. Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts.
Komano Y; Nanki T; Hayashida K; Taniguchi K; Miyasaka N
Arthritis Res Ther; 2006; 8(5):R152. PubMed ID: 16987426
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of mevastatin and a geranylgeranyl transferase I inhibitor (GGTI-2166) on mononuclear osteoclast formation induced by receptor activator of NF kappa B ligand (RANKL) or tumor necrosis factor-alpha (TNF-alpha).
Woo JT; Nakagawa H; Krecic AM; Nagai K; Hamilton AD; Sebti SM; Stern PH
Biochem Pharmacol; 2005 Jan; 69(1):87-95. PubMed ID: 15588717
[TBL] [Abstract][Full Text] [Related]
13. Expression of fusion regulatory proteins (FRPs) on human peripheral blood monocytes. Induction of homotypic cell aggregation and formation of multinucleated giant cells by anti-FRP-1 monoclonal antibodies.
Tabata N; Ito M; Shimokata K; Suga S; Ohgimoto S; Tsurudome M; Kawano M; Matsumura H; Komada H; Nishio M
J Immunol; 1994 Oct; 153(7):3256-66. PubMed ID: 8089497
[TBL] [Abstract][Full Text] [Related]
14. RANKL-stimulated osteoclast-like cell formation in vitro is partially dependent on endogenous interleukin-1 production.
Lee SK; Gardner AE; Kalinowski JF; Jastrzebski SL; Lorenzo JA
Bone; 2006 May; 38(5):678-85. PubMed ID: 16309985
[TBL] [Abstract][Full Text] [Related]
15. Regulation of osteoclast differentiation and function by receptor activator of NFkB ligand and osteoprotegerin.
Shiotani A; Takami M; Itoh K; Shibasaki Y; Sasaki T
Anat Rec; 2002 Oct; 268(2):137-46. PubMed ID: 12221720
[TBL] [Abstract][Full Text] [Related]
16. Receptor activator of nuclear factor-kappa B ligand induces osteoclast formation in RAW 264.7 macrophage cells via augmented production of macrophage-colony-stimulating factor.
Islam S; Hassan F; Tumurkhuu G; Dagvadorj J; Koide N; Naiki Y; Yoshida T; Yokochi T
Microbiol Immunol; 2008 Dec; 52(12):585-90. PubMed ID: 19120972
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of beta-cryptoxanthin on osteoclast-like cell formation in mouse marrow cultures.
Uchiyama S; Yamaguchi M
Biochem Pharmacol; 2004 Apr; 67(7):1297-305. PubMed ID: 15013845
[TBL] [Abstract][Full Text] [Related]
18. Colony-stimulating factor-1 stimulates the fusion process in osteoclasts.
Amano H; Yamada S; Felix R
J Bone Miner Res; 1998 May; 13(5):846-53. PubMed ID: 9610749
[TBL] [Abstract][Full Text] [Related]
19. Receptor activator of NF-kappaB ligand-stimulated osteoclastogenesis in mouse marrow culture is suppressed by zinc in vitro.
Yamaguchi M; Uchiyama S
Int J Mol Med; 2004 Jul; 14(1):81-5. PubMed ID: 15202020
[TBL] [Abstract][Full Text] [Related]
20. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
